Nancy H.l. Leung - Epidemiology

Author Information

Nancy H. L. Leung is affiliated with the WHO Collaborating Centre for Infectious Disease Epidemiology and Control at the School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China. Her research primarily focuses on infectious diseases, particularly respiratory viruses such as influenza and COVID-19.

Research Contributions

Nancy H. L. Leung has made significant contributions to the field of epidemiology, with a particular focus on the transmission and immunogenicity of respiratory viruses. Her work has provided insights into the temporal distribution of viral loads and the real-time estimation of COVID-19 transmission. She has also explored the strength and durability of antibody responses to various vaccines, the impact of influenza vaccination in different populations, and the efficacy of face masks in controlling respiratory virus shedding. Her research is highly relevant for public health policies, particularly in the context of pandemic preparedness and response.

Aliases

Nancy H. L. Leung is also known by several aliases including Nancy Hl Leung, Nancy H. Leung, Nancy H L Leung, Nancy H.l. Leung, and Nancy Leung.

Publication and Citation Metrics

Metric	Value
Total Citations	3128
h-index	16
Total Papers	39

Publications:

Incorporating temporal distribution of population-level viral load enables real-time estimation of COVID-19 transmission

DOI: 10.1038/s41467-022-28812-9

Year: 2022

Strength and durability of antibody responses to BNT162b2 and CoronaVac

DOI: 10.1101/2022.02.11.22270848

Year: 2022

Biphasic waning of hemagglutination inhibition antibody titers after influenza vaccination in children.

DOI: 10.1093/infdis/jiac117

Year: 2022

Transmissibility and transmission of respiratory viruses

DOI: 10.1038/s41579-021-00535-6

Year: 2021

Incorporating temporal distribution of population-level viral load enables real-time estimation of COVID-19 transmissibility

DOI: 10.21203/rs.3.rs-841953/v1

Year: 2021

Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults

DOI: 10.1038/s41541-021-00289-5

Year: 2021

Viral RNA and infectious influenza virus on mobile phones of influenza patients in Hong Kong and the United States.

DOI: 10.1093/infdis/jiab464

Year: 2021

Upper Respiratory Infections in Schools and Childcare Centers Reopening after COVID-19 Dismissals, Hong Kong

DOI: 10.3201/eid2705.210277

Year: 2021

Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults

DOI: 10.1002/cti2.1107

Year: 2020

Respiratory virus shedding in exhaled breath and efficacy of face masks

DOI: 10.1038/s41591-020-0843-2

Year: 2020

What is the Impact of Funding and Resources?

What Are the Challenges in Implementing Digital Health Technologies?

How is the Built Environment Studied in Epidemiology?

How Do Epidemiologists Contribute to Occupational Health?

What strategies can individuals employ to verify information?

Why are Economic Evaluations Important?

Why are HIAs Important?

What is Performance Monitoring in Epidemiology?

What is Non-Generalizability?

What is the significance of genetic variation in pathogens?

Partnered Content Networks

Relevant Topics